When Two Maladies Meet: Disease Burden and Pathophysiology of Stroke in Cancer
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Stroke and cancer are disabling diseases with an enormous global burden, disproportionately affecting vulnerable populations and low- and middle-income countries. Both these diseases share common risk factors, which warrant concerted attention toward reshaping population health approaches and the conducting of fundamental studies. In this article, an overview of epidemiological trends in the prevalence and burden of cancer and stroke, underlying biological mechanisms and clinical risk factors, and various tools available for risk prediction and prognosis are provided. Finally, future recommendations for research and existing gaps in our understanding of pathophysiology. Further research must investigate the causes that predispose patients to an increased risk of stroke and/or cancer, as well as biomarkers that can be used to predict growing morbidity and mortality.
Hawwas M, Mancy A, Ramadan M, Ibrahim T, Bayoumi A, Alswah M Mol Divers. 2025; .
PMID: 40056327 DOI: 10.1007/s11030-025-11127-4.
Leukemia and risk of stroke: a Mendelian randomization analysis.
Yi X, Zhu J, Zhang X, Huang N, Cheng Y BMC Neurol. 2025; 25(1):68.
PMID: 39972428 PMC: 11837699. DOI: 10.1186/s12883-025-04079-7.
Menounos S, Shen H, Tipirneni S, Bhaskar S Biomolecules. 2025; 14(12.
PMID: 39766214 PMC: 11673144. DOI: 10.3390/biom14121507.
Epigenetic age and long-term cancer risk following a stroke.
Suarez-Perez A, Macias-Gomez A, Fernandez-Perez I, Vallverdu-Prats M, Cuadrado-Godia E, Giralt-Steinhauer E Genome Med. 2024; 16(1):135.
PMID: 39578904 PMC: 11583382. DOI: 10.1186/s13073-024-01408-2.
Situmorang P, Ilyas S, Nugraha S, Syahputra R, Nik Abd Rahman N Front Pharmacol. 2024; 15:1387866.
PMID: 39104398 PMC: 11298448. DOI: 10.3389/fphar.2024.1387866.